RSS   Newsletter   Contact   Advertise with us
Post Online Media

Chiasma names Mark Fitzpatrick CEO

Mark J FitzpatrickChiasma, a biopharmaceutical company, announced that Mark J. Fitzpatrick has been appointed president and chief executive officer and a member of the board of directors, effective October 1, 2016.

Mr. Fitzpatrick currently serves as Chiasma’s Chief Financial Officer. Mr. Fitzpatrick joined Chiasma as its Chief Financial Officer in June 2015 and has over 25 years of experience in the biotechnology industry.

Article continues below

READ MORE Chiasma appoints Mark J. Fitzpatrick as CFO

He has held the senior-most financial leadership position and reported directly to the CEO of both public and private technology companies since 1991.

Prior to Aegerion, Mr. Fitzpatrick was vice president, CFO and assistant secretary at Proteon Therapeutics, Inc. and vice president and CFO, treasurer and assistant secretary at RenaMed Biologics, Inc.

He also held CFO positions with Dynogen Pharmaceuticals, WorldStreet Corporation and Diacrin. Mr. Fitzpatrick previously was a senior auditor with Arthur Andersen & Co.

He earned a Certified Public Accountant certificate in the Commonwealth of Massachusetts in 1987, and holds a B.S. in Accounting from Boston College.

He succeeds Mark Leuchtenberger, who has stepped down as Chief Executive Officer to pursue other opportunities.


 LATEST MOVES FROM Massachusetts 


 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy